What is the oral dose and mechanism of action of cefazolin (Cefazolin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefazolin Mechanism of Action and Administration Route

Cefazolin is only available as a parenteral (intravenous or intramuscular) formulation and has no oral dosage form available for clinical use. 1

Mechanism of Action

Cefazolin is a first-generation cephalosporin antibiotic that works by:

  • Inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs)
  • Disrupting the final transpeptidation step of peptidoglycan synthesis
  • Causing bacterial cell lysis through activation of autolytic enzymes

Antimicrobial Spectrum

Cefazolin demonstrates excellent activity against:

  • Gram-positive organisms: Streptococcus pneumoniae, Staphylococcus aureus (methicillin-susceptible), and group A streptococci 2, 3
  • Some gram-negative organisms: Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis 2, 3

However, cefazolin has limited activity against:

  • Enterobacter species
  • Indole-positive Proteus
  • Pseudomonas aeruginosa
  • Enterococci 2

Parenteral Administration

Since cefazolin is only available in parenteral form, the standard dosing includes:

  • Intravenous (IV): 1-2g every 8 hours for most infections 1
  • Intramuscular (IM): 1g provides mean peak serum concentrations of 38.8 μg/ml at 1 hour post-injection 4
  • Subcutaneous (SC): An alternative route with 74.8% bioavailability compared to IV administration 5

Clinical Applications

Cefazolin is primarily used for:

  1. Surgical prophylaxis: Single dose of 1-2g IV (with reinjection if surgery exceeds 4 hours) 1
  2. Infective endocarditis prophylaxis: Alternative for penicillin-allergic patients who cannot take oral medication - 1g IV/IM for adults, 50 mg/kg for children 1
  3. Treatment of skin and soft tissue infections: Particularly those caused by methicillin-susceptible S. aureus 1

Pharmacokinetics

  • Half-life: Approximately 2-2.7 hours in patients with normal renal function 6, 4
  • Protein binding: High (81%), which affects its antibacterial activity in serum 4
  • Elimination: Primarily renal, with dosage adjustments needed in patients with impaired kidney function 6

Important Clinical Considerations

  • Cefazolin has minimal pain upon intramuscular injection, making it preferable to some other parenteral antibiotics 2, 3
  • For patients requiring oral therapy, appropriate alternatives include:
    • Cephalexin (first-generation oral cephalosporin)
    • Cefuroxime or cefprozil (second-generation oral cephalosporins)
    • Cefpodoxime or cefdinir (third-generation oral cephalosporins) 7

Cautions and Contraindications

  • Cross-reactivity with penicillin allergy: Cephalosporins should not be administered to patients with history of anaphylaxis, angioedema, or urticaria after penicillin treatment 1
  • Elderly patients (>60 years) may have prolonged excretion time, potentially requiring dosage adjustment 6

Remember that when oral antibiotic therapy is needed, an appropriate oral cephalosporin or alternative antibiotic class must be selected based on the infection type and suspected pathogens, as cefazolin itself is not available in oral form.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of cefazolin, a new cephalosporin antibiotic.

Antimicrobial agents and chemotherapy, 1973

Research

Bactericidal activity and pharmacology of cefazolin.

Antimicrobial agents and chemotherapy, 1973

Guideline

Cephalosporin Antibiotics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.